SCHEMBL5487252

SCHEMBL5487252

COc1ccc(C=Cc2ccc(N(c3ccc(OC)c(C)c3)c3ccc(OC)c(C)c3)cc2)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.55
TUBB1 Q9H4B7 10/20 0.50
CYP1A1 P04798 4/20 0.47
TUBB4A P04350 3/20 0.47
TUBB P07437 3/20 0.47
TUBA3C P0DPH7 3/20 0.47
TUBA1B P68363 3/20 0.47
TUBA4A P68366 3/20 0.47
TUBB4B P68371 3/20 0.47
TUBB3 Q13509 3/20 0.47
TUBB2A Q13885 3/20 0.47
TUBB8 Q3ZCM7 3/20 0.47
TUBA3E Q6PEY2 3/20 0.47
TUBA1A Q71U36 3/20 0.47
TUBA1C Q9BQE3 3/20 0.47
TUBB6 Q9BUF5 3/20 0.47
TUBB2B Q9BVA1 3/20 0.47
CYP1B1 Q16678 3/20 0.47
CYP1A2 P05177 1/20 0.47
NFE2L2 Q16236 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10015727 0.88 NQO2 (0.61) NQO2TUBB1CYP1A1TUBB4ATUBB
SCHEMBL5492437 0.84 TRPA1 (0.44) NQO2TUBB1CYP1A1TUBB4ATUBB
SCHEMBL16168067 0.83 NQO2 (0.77) NQO2TUBB1CYP1A1TUBB4ATUBB
SCHEMBL13898796 0.81 TUBB1 (0.46) NQO2TUBB1NFE2L2ALDH1A1MAPT
SCHEMBL14363441 0.80 CYP1A1 (0.73) NQO2TUBB1CYP1A1TUBB4ATUBB
SCHEMBL13050008 0.77 APP (0.44) NQO2TUBB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL13978801 0.77 TUBB1 (0.49) NQO2TUBB1NFE2L2ALDH1A1MAPT
SCHEMBL10015732 0.77 TUBB1 (0.49) NQO2TUBB1NFE2L2ALDH1A1MAPT
SCHEMBL10047112 0.76 NQO2 (0.67) NQO2TUBB1CYP1A1TUBB4ATUBB
SCHEMBL18085345 0.76 TUBB1 (0.49) NQO2TUBB1CYP1A1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276627-B2 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-10-02 US claimed
US-20060224017-A1 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2006-10-05 US claimed
US-7276627-B2 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-10-02 US disclosed
US-20060224017-A1 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060224017-A1 One pot sequential reactions and novel products produced thereby PNMT, CYP1A1, TERT NQO2 164/4885TUBB1 3033/4885CYP1A1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.